Elanco Animal Health Incorporated Number of Reporting Units
Elanco Animal Health Incorporated (ELAN) reported Number of Reporting Units of 1 report for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Notes
us-gaap:NumberOfReportingUnits · last filed 2026-02-24
- Elanco Animal Health Incorporated number of reporting units for the quarter ending 2024-03-31 was 1.00 reporting_unit.
reporting_unit
| Period end | Number of Reporting Units 3 month | Number of Reporting Units 6 month | Number of Reporting Units 9 month |
|---|---|---|---|
| 2024-09-30 | 1.00 reporting_unit 10-Q · filed 2024-11-07 | ||
| 2024-06-30 | 1.00 reporting_unit 10-Q · filed 2024-08-08 | ||
| 2024-03-31 | 1.00 reporting_unit 10-Q · filed 2024-05-08 |
report
| Period end | Number of Reporting Units 12 month |
|---|---|
| 2025-12-31 | 1.00 report 10-K · filed 2026-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |